| Literature DB >> 30379886 |
Venu Perla1, Marjan Nadimi1, Rishi Reddy1, Gerald R Hankins1, Padma Nimmakayala1, Robert T Harris1, Jagan Valluri2, Cristian Sirbu3, Umesh K Reddy1.
Abstract
Chili peppers are an important constituent of many foods and contain medicinally valuable compounds, such as capsaicin and dihydrocapsaicin. As various dietary botanicals have anticancer properties, this study was aimed to examine the effect of Ghost pepper (Bhut Jolokia), one of the hottest chili peppers in the world, on cell proliferation, apoptosis, senescence and the global proteomic profile in human renal cell adenocarcinoma in vitro. 769-P human renal adenocarcinoma cells were cultured on RPMI-1640 media supplemented with fetal bovine serum (10%) and antibiotic-antimycotic solution (1%). Treatment stock solutions were prepared in ethanol. Cell proliferation was tested with phenol red-free media with capsaicin (0-400 μM), dihydrocapsaicin (0-400 μM), capsaicin + dihydrocapsaicin (5:1), and dry Ghost peppers (0-3 g L-1) for 24, 48 and 72 h. Polycaspase and senescence associated-beta-galactosidase (SA-beta-gal) activities were tested with capsaicin (400 μM), dihydrocapsaicin (400 μM), capsaicin (400 μM) + dihydrocapsaicin (80 μM), and ghost pepper (3 g L-1) treatments. Global proteomic profile of cells in control and ghost pepper treatment (3 g L-1) was analyzed after 6 h by a shotgun proteomic approach using tandem mass spectrometry. At 24 h after treatment (24 HAT), relative to control, cell proportion with capsaicin (400 μM), dihydrocapsaicin (400 μM), capsaicin (400 μM) + dihydrocapsaicin (80 μM), and ghost pepper (3 g L-1) treatments was reduced to 36%, 18%, 33% and 20%, respectively, and further reduced at 48 and 72 HAT. All treatments triggered an early polycaspase response. SA-beta-gal activity was normal or suppressed with all treatments. About 68,220 protein isoforms were identified by shotgun proteomic approach. Among these, about 8.2% were significantly affected by ghost pepper. Ghost pepper regulated various proteins involved in intrinsic and extrinsic apoptotic pathways, Ras, Rb/E2F, p53, TGF-beta, WNT-beta catenin, and calcium induced cell death pathways. Ghost pepper also induced changes in proteins related to methylation, acetylation, genome stability, cell cycle check points, carbohydrate, protein and other metabolism and cellular mechanisms. Ghost pepper exhibited antiproliferation activity by inducing apoptosis through a complex network of proteins in human renal cell adenocarcinoma in vitro.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30379886 PMCID: PMC6209291 DOI: 10.1371/journal.pone.0206183
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Ghost pepper and its major capsaicinoids.
(A) Commercially available dried ripened Ghost pepper fruits. Bar = 1 cm. (B) Capsaicin and dihydrocapsaicin levels in the commercial dried ripened Ghost pepper powder. Values are means ± SD; n = 3; **p ≤ 0.01 (as compared to capsaicin).
Fig 2Effect of ghost pepper on human renal adenocarcinoma cell proliferation.
Percentage of cells at 24, 48 and 72 H with different concentrations of capsaicin (Cap), dihydrocapsaicin (DCap), Cap + DCap (5:1), and ghost pepper. Control (media without any treatment compound) is adjusted to 100%. Values are means ± SD; n = 4; *p ≤ 0.05 and **p ≤ 0.01 (as compared to control); ^p ≤ 0.05 and ^^p ≤ 0.01 (as compared to lowest concentration with in each compound group).
Fig 3Effect of solvent on human renal adenocarcinoma cell proliferation.
Different controls with different levels of ethanol, the solvent used for dissolving capsaicinoids in the study, were tested at 24 and 72 H. Control-1 contains culture media without ethanol. All other controls contain culture media with different levels of ethanol. Control-2, -3, -4 and -5 contained 0.2, 0.4, 0.6 and 0.8% ethanol, respectively. These were the corresponding controls for 100, 200, 300 and 400 μM capsaicin as well as dihydrocapsaicin treatments; and 0.75, 1.50, 2.25 and 3.00 g L-1 ghost pepper treatments, respectively. Control-6, -7, -8 and -9 contained 0.24, 0.48, 0.72 and 0.96% ethanol, respectively. These were the corresponding controls for 100 + 20; 200 + 40; 300 + 60; and 400 + 80 μM capsaicin + dihydrocapsaicin treatments, respectively (refer Fig 2 for treatments). Values are mean ± SD; n = 4; NS = Not significantly different from control-1 (p ≤ 0.05).
Fig 4Cellular polycaspase activity in human renal adenocarcinoma cells at 0.5, 1, 2 and 4 H.
Control-1 contained culture media without ethanol. Control-2 and control-3 contained culture media with different levels of ethanol (0.80 and 0.96%, respectively). Control (+ve) contained staurosporine (6 μM). Control-2 was a corresponding control for capsaicin (Cap 400 μM), dihydrocapsaicin (DCap 400 μM), and Ghost pepper (3 g L-1) treatments. Control-3 was a corresponding control for capsaicin + dihydrocapsaicin treatment (Cap 400 μM + DCap 80 μM) (5:1). Polycaspase activities were normalized with respective total number of cells. Values are means ± SD; n = 4; p ≤ 0.05 (*, ^, + or ! ); p ≤ 0.01 (**, ^^, ++ or !!); * or ** as compared to control-1; ^ or ^^ as compared to cap 400 μM; + or ++ as compared to DCap 400 μM; ! or !! as compared to Cap 400 μM + DCap 80 μM.
Fig 5SA-beta-gal activity in human renal adenocarcinoma cells at 0.5, 1 and 2 H.
Control-1 contained culture media without ethanol. Control-2 and control-3 contained culture media with different levels of ethanol (0.80 and 0.96%, respectively). Control-2 was a corresponding control for capsaicin (Cap 400 μM), dihydrocapsaicin (DCap 400 μM), and ghost pepper (3 g L-1) treatments. Control-3 was a corresponding control for capsaicin + dihydrocapsaicin treatment (Cap 400 μM + DCap 80 μM) (5:1). SA-beta-gal activities were normalized with respective relative fluorescence unit (RFU) values obtained with CyQUANT cell proliferation assay. Values are mean ± SD; n = 4; p ≤ 0.05 (*, ^, + or ! ); p ≤ 0.01 (**, ^^, ++ or !!); * or ** as compared to control-1; ^ or ^^ as compared to Cap 400 μM; + or ++ as compared to DCap 400 μM; ! or !! as compared to Cap 400 μM + DCap 80 μM.
Selective list of proteins that were affected by ghost pepper (3 g L-1) at 6 H.
| S. No. | Protein | Gene name | Description | Protein Intensity Values | Fold change | Experimental evidence | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Control (C) | Ghost Pepper (T) | |||||||||||
| Mean | SD | Mean | SD | |||||||||
| 1 | A0A024R374 | Cathepsin B, isoform CRA_a | 385.36 | 20.01 | 210.87 | 77.26 | 1.83 | 0.038 | UR, protein inferred from homology | |||
| 2 | C9JL25 | 60 kDa heat shock protein, mitochondrial | 611.49 | 212.73 | 1589.49 | 348.72 | -2.60 | 0.036 | ||||
| 3 | H0YF14 | Bcl-2-associated transcription factor 1 | 8.59 | 13.14 | 38.67 | 19.92 | -4.50 | 0.028 | UR, protein predicted | |||
| 4 | I3L276 | Heme oxygenase 2 | 64.98 | 110.82 | 208.33 | 144.13 | -3.21 | 0.031 | UR, protein | |||
| 5 | O43715 | TP53-regulated inhibitor of apoptosis 1 | 49.04 | 19.75 | 1.00 | 0.00 | 49.04 | 0.052 | Protein | |||
| 6 | P04040 | Catalase | 37.92 | 55.59 | 236.27 | 118.47 | -6.23 | 0.043 | Protein | |||
| 7 | P06681 | Complement C2 | 1.00 | 0.00 | 3.14 | 0.09 | -3.14 | 0.001 | Protein | |||
| 8 | P19440 | Gamma-glutamyltranspeptidase 1 | 106.01 | 40.01 | 191.53 | 16.71 | -1.81 | 0.032 | Protein | |||
| 9 | P51398 | 28S ribosomal protein S29, mitochondrial | 73.78 | 59.58 | 277.07 | 55.12 | -3.76 | 0.001 | Protein | |||
| 10 | P60602 | Reactive oxygen species modulator 1 | 1.75 | 1.29 | 41.46 | 2.47 | -23.74 | <0.001 | Protein | |||
| 11 | P99999 | Cytochrome c | 127.48 | 29.51 | 26.14 | 21.19 | 4.88 | 0.041 | Protein | |||
| 12 | Q12888 | Tumor suppressor p53-binding protein 1 | 65.68 | 64.28 | 342.75 | 76.21 | -5.22 | 0.036 | Protein | |||
| 13 | Q12933 | TNF receptor-associated factor 2 | 18.41 | 15.87 | 43.61 | 15.48 | -2.37 | <0.001 | Protein | |||
| 14 | Q4LDX3 | Janus kinase 1 | 56.37 | 22.82 | 242.90 | 33.34 | -4.31 | 0.029 | UR, transcript | |||
| 15 | Q5TCM1 | Superoxide dismutase [Mn], mitochondrial | 85.17 | 35.32 | 533.48 | 75.31 | -6.26 | 0.003 | Protein | |||
| 16 | Q6LCB0 | FADD protein | 46.88 | 19.46 | 4.60 | 6.24 | 10.19 | 0.049 | UR, protein predicted | |||
| 17 | Q8NC60 | Nitric oxide-associated protein 1 | 12.51 | 12.39 | 79.27 | 29.34 | -6.33 | 0.022 | Protein | |||
| 18 | Q96FV9 | THO complex subunit 1 | 25.48 | 21.26 | 108.04 | 20.66 | -4.24 | 0.001 | Protein | |||
| 19 | Q96G23 | Ceramide synthase 2 | 7.61 | 11.45 | 58.99 | 20.92 | -7.75 | 0.013 | Protein | |||
| 20 | Q96NN9 | Apoptosis-inducing factor 3 | 28.45 | 6.83 | 2.60 | 2.78 | 10.92 | 0.017 | Protein | |||
| 21 | Q99439 | Calponin-2 | 883.51 | 220.67 | 632.19 | 165.33 | 1.40 | 0.036 | Protein | |||
| 22 | Q9HBQ7 | Cathepsin L, isoform CRA_b | 119.88 | 41.31 | 5.83 | 8.36 | 20.57 | 0.031 | UR, transcript | |||
| 23 | Q9NP84 | Tumor necrosis factor receptor superfamily member 12A | 1.00 | 0.00 | 50.27 | 6.83 | -50.27 | 0.006 | Protein | |||
| 24 | Q9UC56 | Stress-70 protein, mitochondrial | 3109.41 | 588.93 | 5240.18 | 193.78 | -1.69 | 0.037 | Protein | |||
| 25 | R4GNE4 | Glutathione peroxidase | 27.68 | 24.48 | 143.12 | 33.62 | -5.17 | 0.032 | UR, protein | |||
| 26 | W8Q444 | Superoxide dismutase-1 | 10.31 | 8.55 | 34.38 | 0.73 | -3.34 | 0.039 | UR, protein predicted | |||
| 27 | B0LPH5 | Protein kinase C, alpha | 1.00 | 0.00 | 32.06 | 6.67 | -32.06 | 0.015 | UR, protein predicted | |||
| 28 | B2R841 | Serine/threonine-protein kinase PLK | 25.18 | 20.07 | 114.95 | 18.14 | -4.56 | <0.001 | UR, transcript | |||
| 29 | H3BLV9 | SRSF protein kinase 1 | 51.13 | 20.64 | 172.98 | 25.24 | -3.38 | <0.001 | UR, protein | |||
| 30 | P41240 | Tyrosine-protein kinase CSK | 29.24 | 17.70 | 57.75 | 24.52 | -1.97 | 0.036 | Protein | |||
| 31 | P49137 | MAP kinase-activated protein kinase 2 | 4.44 | 5.96 | 25.34 | 6.36 | -5.71 | 0.028 | Protein | |||
| 32 | Q9HC98 | Serine/threonine-protein kinase Nek6 | 4.34 | 2.96 | 12.88 | 3.22 | -2.97 | 0.005 | Protein | |||
| 33 | X5DP03 | Serine threonine kinase 39 isoform B | 12.95 | 10.70 | 109.18 | 33.11 | -8.43 | 0.019 | UR, transcript | |||
| 34 | F5H6R7 | Ras-related protein Rap-1b | 64.63 | 12.98 | 158.16 | 15.86 | -2.45 | 0.002 | UR, protein | |||
| 35 | F8VUA5 | Ras-related protein Rab-5B | 1.00 | 0.00 | 36.29 | 11.54 | -36.29 | 0.034 | UR, protein | |||
| 36 | H0YEI0 | Ras association domain-containing protein 7 | 4.57 | 6.18 | 51.57 | 6.22 | -11.29 | <0.001 | UR, protein predicted | |||
| 37 | Q53EX5 | RAB7, member RAS oncogene family-like 1 variant | 1.00 | 0.00 | 50.66 | 17.75 | -50.66 | 0.040 | UR, transcript | |||
| 38 | Q86WH2 | Ras association domain-containing protein 3 | 1.00 | 0.00 | 3.04 | 0.05 | -3.04 | <0.001 | Protein | |||
| 39 | B5BU32 | Thymidine kinase | 33.53 | 13.44 | 109.04 | 20.27 | -3.25 | 0.048 | UR, transcript | |||
| 40 | Q15291 | Retinoblastoma-binding protein 5 | 5.13 | 4.10 | 83.20 | 22.88 | -16.22 | 0.034 | Protein | |||
| 41 | Q14999 | Cullin-7 | 1.62 | 1.08 | 4.93 | 1.63 | -3.03 | 0.044 | Protein | |||
| 42 | Q5VUP6 | Cell division cycle and apoptosis regulator protein 1 | 36.96 | 32.65 | 288.28 | 56.87 | -7.80 | 0.013 | Protein | |||
| 43 | Q9UE85 | Promyelocytic leukemia gene protein | 2.20 | 2.08 | 91.49 | 36.45 | -41.58 | 0.046 | UR, protein predicted | |||
| 44 | O00632 | Menin | 1.64 | 1.11 | 44.76 | 16.25 | -27.24 | 0.043 | Protein | |||
| 45 | O43219 | Transforming growth factor-beta-induced protein ig-h3 | 2.53 | 2.65 | 102.06 | 32.07 | -40.37 | 0.028 | Protein | |||
| 46 | Q9NYJ8 | TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 | 1.00 | 0.00 | 5.75 | 0.06 | -5.75 | <0.001 | Protein | |||
| 47 | B4DGU4 | Catenin beta-1 | 232.42 | 60.04 | 383.84 | 50.49 | -1.65 | 0.002 | UR, protein | |||
| 48 | P35221 | Catenin alpha-1 | 1239.53 | 50.27 | 1050.70 | 87.86 | 1.18 | 0.025 | Protein | |||
| 49 | Q9NQB3 | Transcription factor 7-like 2 | 1.00 | 0.00 | 3.06 | 0.02 | -3.06 | <0.001 | Protein | |||
| 50 | G3V361 | Calmodulin | 735.69 | 97.72 | 297.04 | 49.00 | 2.48 | 0.012 | UR, protein | |||
| 51 | H0Y9S7 | Calcium-transporting ATPase type 2C member 1 | 4.38 | 5.85 | 82.00 | 12.83 | -18.72 | 0.012 | UR, protein | |||
| 52 | Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 101.40 | 34.62 | 12.72 | 6.11 | 7.97 | 0.033 | Protein | |||
| 53 | Q8IWX8 | Calcium homeostasis endoplasmic reticulum protein | 45.89 | 13.40 | 228.61 | 7.60 | -4.98 | 0.002 | Protein | |||
| 54 | Q8NE86 | Calcium uniporter protein, mitochondrial | 51.21 | 48.90 | 222.46 | 38.65 | -4.34 | 0.021 | Protein | |||
| 55 | Q9H712 | Calcium-responsive transcription factor | 1.69 | 1.19 | 3.85 | 1.71 | -2.28 | 0.019 | Protein | |||
| 56 | Q9ULQ1 | Two pore calcium channel protein 1 | 1.00 | 0.00 | 27.70 | 1.27 | -27.70 | 0.001 | Protein | |||
| 57 | Q9Y6Y1 | Calmodulin-binding transcription activator 1 | 7.99 | 3.45 | 4.43 | 4.03 | 1.81 | 0.049 | Protein | |||
| 58 | Q16566 | Calcium/calmodulin-dependent protein kinase type IV | 1.00 | 0.00 | 2.91 | 0.21 | -2.91 | 0.004 | Protein | |||
| 59 | A6N6J7 | JARID1C protein | 8.63 | 13.22 | 24.33 | 11.86 | -2.82 | 0.031 | UR, transcript | |||
| 60 | F8WAX2 | Protein-L-isoaspartate(D-aspartate) O-methyltransferase | 21.35 | 4.97 | 1.00 | 0.00 | 21.35 | 0.019 | ||||
| 61 | H7C2I1 | Protein arginine N-methyltransferase 1 | 415.06 | 80.67 | 836.76 | 116.95 | -2.02 | 0.020 | UR, protein | |||
| 62 | K7EMU8 | DNA (cytosine-5)-methyltransferase 1 | 6.38 | 9.31 | 28.80 | 9.81 | -4.52 | 0.001 | UR, protein | |||
| 63 | P22087 | rRNA 2'-O-methyltransferase fibrillarin | 472.15 | 13.49 | 910.54 | 78.17 | -1.93 | 0.007 | Protein | |||
| 64 | Q15047 | Histone-lysine N-methyltransferase SETDB1 | 2.45 | 2.51 | 27.03 | 2.34 | -11.03 | 0.006 | Protein | |||
| 65 | Q672J1 | Histone-lysine N-methyltransferase NSD2 | 16.83 | 25.92 | 93.37 | 51.46 | -5.55 | 0.038 | Protein | |||
| 66 | Q96KB0 | Bifunctional lysine-specific demethylase and histidyl-hydroxylase MINA | 8.62 | 11.57 | 115.01 | 35.32 | -13.34 | 0.045 | Protein | |||
| 67 | Q9HBJ3 | Histone-lysine N-methyltransferase 2A | 19.02 | 6.52 | 6.08 | 5.04 | 3.13 | 0.004 | Protein | |||
| 68 | Q9UI30 | Multifunctional methyltransferase subunit TRM112-like protein | 249.20 | 8.85 | 131.01 | 21.43 | 1.90 | 0.016 | Protein | |||
| 69 | Q9Y483 | Metal-response element-binding transcription factor 2 | 3.73 | 3.31 | 21.39 | 3.64 | -5.73 | 0.016 | Protein | |||
| 70 | A1Z5I6 | Mediator of DNA damage checkpoint 1 variant 2 | 1.00 | 0.00 | 14.60 | 3.40 | -14.60 | 0.020 | UR, transcript | |||
| 71 | B4DTU4 | DNA ligase | 59.25 | 13.36 | 364.20 | 85.60 | -6.15 | 0.019 | UR, protein | |||
| 72 | B7ZVY7 | Cell division cycle 2-like 1 (PITSLRE proteins) | 4.10 | 5.36 | 39.94 | 13.83 | -9.75 | 0.049 | UR, protein | |||
| 73 | H0Y9J8 | Cell cycle checkpoint protein RAD17 | 1.00 | 0.00 | 6.01 | 0.10 | -6.01 | <0.001 | UR, protein | |||
| 74 | Q13042 | Cell division cycle protein 16 homolog | 10.88 | 7.34 | 38.82 | 12.02 | -3.57 | 0.040 | Protein | |||
| 75 | Q15819 | Ubiquitin-conjugating enzyme E2 variant 2 | 352.73 | 88.39 | 3.05 | 2.23 | 115.67 | 0.020 | Protein | |||
| 76 | Q16695 | Histone H3.1t | 332.58 | 28.97 | 526.29 | 72.26 | -1.58 | 0.018 | Protein | |||
| 77 | Q7Z2J1 | Transcriptional regulator ATRX | 10.14 | 9.15 | 127.09 | 24.60 | -12.53 | 0.006 | Protein | |||
| 78 | Q8WWL7 | G2/mitotic-specific cyclin-B3 | 11.73 | 5.62 | 32.65 | 2.58 | -2.78 | 0.013 | Protein | |||
| 79 | Q9H9Q9 | Cell cycle and apoptosis regulator protein 2 | 365.06 | 34.83 | 609.51 | 58.77 | -1.67 | 0.035 | Protein | |||
| 80 | Q9NYB0 | Telomeric repeat-binding factor 2-interacting protein 1 | 19.33 | 13.11 | 77.75 | 13.83 | -4.02 | 0.029 | Protein | |||
| 81 | Q9UJX4 | Anaphase-promoting complex subunit 5 | 18.67 | 17.87 | 128.20 | 22.18 | -6.87 | 0.011 | Protein | |||
| 82 | B4DHB3 | Phosphoglycerate kinase | 1176.88 | 352.46 | 362.35 | 135.41 | 3.25 | 0.028 | UR, transcript | |||
| 83 | B4DPM0 | Pyruvate kinase | 283.82 | 35.20 | 78.39 | 7.42 | 3.62 | 0.014 | UR, transcript | |||
| 84 | B4E2U0 | 6-phosphogluconate dehydrogenase, decarboxylating | 290.03 | 65.21 | 123.93 | 54.62 | 2.34 | 0.002 | UR, transcript | |||
| 85 | E9PK47 | Alpha-1,4 glucan phosphorylase | 107.81 | 11.36 | 34.67 | 6.25 | 3.11 | 0.015 | UR, protein | |||
| 86 | F2Z393 | Transaldolase | 593.53 | 58.68 | 288.03 | 71.42 | 2.06 | 0.034 | UR, protein | |||
| 87 | H3BR68 | Fructose-bisphosphate aldolase A | 624.56 | 31.44 | 181.07 | 28.45 | 3.45 | 0.001 | UR, protein | |||
| 88 | H3BU13 | Pyruvate kinase PKM | 943.35 | 81.53 | 566.89 | 16.86 | 1.66 | 0.014 | UR, protein | |||
| 89 | H3BUH7 | Fructose-bisphosphate aldolase A | 2238.98 | 467.51 | 522.35 | 48.65 | 4.29 | 0.028 | UR, protein | |||
| 90 | K7EM90 | Enolase | 2210.71 | 635.82 | 1102.74 | 269.53 | 2.00 | 0.036 | UR, protein | |||
| 91 | K7ENA0 | Glucose-6-phosphate isomerase | 368.63 | 66.05 | 85.26 | 75.23 | 4.32 | <0.001 | UR, protein | |||
| 92 | P09467 | Fructose-1,6-bisphosphatase 1 | 7.76 | 6.05 | 12.31 | 6.50 | -1.59 | 0.020 | Protein | |||
| 93 | P52209 | 6-phosphogluconate dehydrogenase, decarboxylating | 377.41 | 54.26 | 187.45 | 41.03 | 2.01 | 0.010 | Protein | |||
| 94 | Q6FI37 | Isocitrate dehydrogenase [NADP] | 313.47 | 98.23 | 42.60 | 5.33 | 7.36 | 0.045 | UR, transcript | |||
| 95 | Q9UF08 | Glycogen debranching enzyme | 29.74 | 13.50 | 59.31 | 19.42 | -1.99 | 0.018 | Protein | |||
| 96 | U3KPS5 | Triosephosphate isomerase | 377.22 | 28.00 | 199.33 | 46.94 | 1.89 | 0.012 | UR, protein | |||
| 97 | U3KQP4 | Gamma-enolase | 56.15 | 22.11 | 8.23 | 12.52 | 6.83 | 0.018 | UR, protein | |||
| 98 | F8VS27 | Elongation factor Ts, mitochondrial | 1.00 | 0.00 | 55.29 | 6.52 | -55.29 | 0.005 | UR, protein | |||
| 99 | P39023 | 60S ribosomal protein L3 | 647.05 | 227.22 | 1161.78 | 211.18 | -1.80 | 0.001 | Protein | |||
| 100 | Q05639 | Elongation factor 1-alpha 2 | 3113.93 | 773.57 | 1862.76 | 488.17 | 1.67 | 0.017 | Protein | |||
| 101 | Q6PI48 | Aspartate—tRNA ligase, mitochondrial | 138.13 | 13.89 | 317.58 | 15.14 | -2.30 | <0.001 | Protein | |||
| 102 | Q9Y3D9 | 28S ribosomal protein S23, mitochondrial | 8.12 | 12.33 | 58.22 | 8.90 | -7.17 | 0.003 | Protein | |||
| 103 | D6RHI2 | Elongation of very long chain fatty acids protein | 1.00 | 0.00 | 5.72 | 0.01 | -5.72 | <0.001 | UR, protein inferred from homology | |||
| 104 | F8VQZ7 | Methionine aminopeptidase 2 | 139.59 | 53.31 | 6.09 | 8.81 | 22.93 | 0.044 | UR, protein | |||
| 105 | P51648 | Fatty aldehyde dehydrogenase | 39.06 | 25.75 | 234.48 | 18.06 | -6.00 | 0.012 | Protein | |||
| 106 | Q02880 | DNA topoisomerase 2-beta | 77.70 | 7.32 | 272.66 | 6.13 | -3.51 | 0.001 | Protein | |||
| 107 | Q6ICD2 | Eukaryotic translation initiation factor 3 subunit L | 419.15 | 75.34 | 220.10 | 68.41 | 1.90 | 0.002 | Protein | |||
*Area under the curve of peptide peak (no units).
$Fold change of a protein is a ratio of its expression in control and ghost pepper treated cells (n = 3). Negative (-) or positive (none) sign under 'fold change' column indicates over or under expression of that protein, respectively in ghost pepper treated cells as compared to control.
^Paired Student's t-test with two-tailed distribution.
#Experimental evidence were obtained from Swiss-Prot website. UR = Unreviewed (protein sequence and functional information are not yet reviewed at Swiss-Prot website).
Fig 6Mechanism of ghost pepper mediated cell death in human renal adenocarcinoma cells.
Ghost pepper induce apoptosis by regulating the expression of key proteins involved in several cellular pathways, molecular mechanisms and metabolism. Enzymatic assays and global proteomic analysis suggest that Ghost pepper induced apoptosis in human renal adenocarcinoma cells was mediated through intrinsic and extrinsic apoptotic pathways, Ras, Rb/E2F, p53, TGF-beta, WNT-beta catenin, and calcium induced cell death pathways. Broadly two types of protein responses were noticed within each pathway. One type of proteins over expressed while other type were down regulated by ghost pepper treatment. These imbalances favored apoptosis rather than cell proliferation in ghost pepper treatment. Besides these pathways, ghost pepper also induced changes in methylation, acetylation, genome stability, cell cycle check points, carbohydrate, protein and other metabolism.